Helicobacter pylori Eradication Can Reverse Rho GTPase Expression in Gastric Carcinogenesis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Altered DNA methylation is a key mechanism of epigenetic modification in gastric cancer (GC). This study aimed to evaluate the changes in epigenetic and genetic expression of multiple Rho GTPases in Helicobacter pylori-related gastric carcinogenesis by comparing H. pylori-positive GCs and negative controls. Methods: The messenger RNA expression and methylation of Rho GTPases (RhoA, Rac1, DOCK180, ELMO1, and CDC42) were evaluated in H. pylori-negative (control) human gastric tissues and H. pylori-positive GCs by using real-time reverse transcription-polymerase chain reaction and the quantitative MethyLight assay, respectively. Changes in expression and methylation levels of the genes were also compared between H. pylori-eradicated and -persistent GCs at 1-year follow-up. Results: In GCs, the methylation and expression levels of DOCK180 and ELMO1 were higher than in controls, while RhoA and Rac1 had lower levels than controls. CDC42 had the same expression pattern as DOCK180 and ELMO1 without DNA methylation. Although methylation levels of DOCK180 and ELMO1 had no difference between H. pylori-eradicated and -persistent GCs at the index endoscopic resection, those of H. pylori-persistent GCs increased and H. pylorieradicated GCs decreased for 1 year. The expression levels of DOCK180, ELMO1, and CDC42 in H. pylori-persistent GCs were higher than those in H. pylori-eradicated GCs over 1 year, unlike those of RhoA and Rac1. The methylation levels at index and the degrees of change over time of RhoA and Rac1 had no difference between H. pylori-persistent and -eradicated GCs. Conclusions: Epigenetic alterations of DOCK180 and ELMO1 are involved in H. pylori-related gastric carcinogenesis. This epigenetic field could be improved by H. pylori eradication.
Abstract
Background/Aims: Altered DNA methylation is a key mechanism of epigenetic modification in gastric cancer (GC). This study aimed to evaluate the changes in epigenetic and genetic expression of multiple Rho GTPases in Helicobacter pylori-related gastric carcinogenesis by comparing H. pylori-positive GCs and negative controls. Methods: The messenger RNA expression and methylation of Rho GTPases (RhoA, Rac1, DOCK180, ELMO1, and CDC42) were evaluated in H. pylori-negative (control) human gastric tissues and H. pylori-positive GCs by using real-time reverse transcription-polymerase chain reaction and the quantitative MethyLight assay, respectively. Changes in expression and methylation levels of the genes were also compared between H. pylori-eradicated and -persistent GCs at 1-year follow-up. Results: In GCs, the methylation and expression levels of DOCK180 and ELMO1 were higher than in controls, while RhoA and Rac1 had lower levels than controls. CDC42 had the same expression pattern as DOCK180 and ELMO1 without DNA methylation. Although methylation levels of DOCK180 and ELMO1 had no difference between H. pylori-eradicated and -persistent GCs at the index endoscopic resection, those of H. pylori-persistent GCs increased and H. pylorieradicated GCs decreased for 1 year. The expression levels of DOCK180, ELMO1, and CDC42 in H. pylori-persistent GCs were higher than those in H. pylori-eradicated GCs over 1 year, unlike those of RhoA and Rac1. The methylation levels at index and the degrees of change over time of RhoA and Rac1 had no difference between H. pylori-persistent and -eradicated GCs. Conclusions: Epigenetic alterations of DOCK180 and ELMO1 are involved in H. pylori-related gastric carcinogenesis. This epigenetic field could be improved by H. pylori eradication.
참고문헌 (36)
- Sung H, "Global Cancer Statistics 2020 : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- Chung SJ, "Effect of annual endoscopic screening on clinicopathologic characteristics and treatment modality of gastric cancer in a high-incidence region of Korea", Int J Cancer, 131, pp.2376~2384 (2012)
- Hirai R, "Feasibility of endoscopic evaluation of Helicobacter pylori infection status by using the Kyoto classification of gastritis in the population-based gastric cancer screening program : a prospective cohort study", Health Sci Rep, 4, pp.e325~ (2021)
- Seiichiro Abe, "Metachronous Gastric Cancer Following Curative Endoscopic Resection of Early Gastric Cancer", Clinical Endoscopy, 51(3), pp.253~259 (2018), 대한소화기내시경학회
- Correa P, "Human gastric carcinogenesis : a multistep and multifactorial process : First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention", Cancer Res, 52, pp.6735~6740 (1992)
- Choi IJ, "Helicobacter pylori therapy for the prevention of metachronous gastric cancer", N Engl J Med, 378, pp.1085~1095 (2018)
- Ushijima T, "Aberrant DNA methylation in contrast with mutations", Cancer Sci, 101, pp.300~305 (2010)
- Calcagno DQ, "DNA and histone methylation in gastric carcinogenesis", World J Gastroenterol, 19, pp.1182~1192 (2013)
- Ziogas D, "Epigenetics in gastric cancer : challenges for clinical implications", Ann Surg Oncol, 16, pp.2077~2078 (2009)
- Tahara T, "DNA methylation as a molecular biomarker in gastric cancer", Epigenomics, 7, pp.475~486 (2015)
- Kang GH, "DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis", Lab Invest, 88, pp.161~170 (2008)
- Pirini F, "Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies", Oncotarget, 8, pp.38501~38516 (2017)
- Ellenbroek SI, "Rho GTPases : functions and association with cancer", Clin Exp Metastasis, 24, pp.657~672 (2007)
- Karlsson R, "Rho GTPase function in tumorigenesis", Biochim Biophys Acta, 1796, pp.91~98 (2009)
- Guan X, "Rho GTPases and related signaling complexes in cell migration and invasion", Exp Cell Res, 388, pp.111824~ (2020)
- Etienne-Manneville S, "Rho GTPases in cell biology", Nature, 420, pp.629~635 (2002)
- Maeda M, "Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication", Gastric Cancer, 21, pp.745~755 (2018)
- Jarzynka MJ, "ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion", Cancer Res, 67, pp.7203~7211 (2007)
- Wessler S, "Molecular mechanisms of epithelialbarrier disruption by Helicobacter pylori", Trends Microbiol, 16, pp.397~405 (2008)
- Wen S, "Helicobacter pylori virulence factors in gastric carcinogenesis", Cancer Lett, 282, pp.1~8 (2009)
- Ahn HJ, "Helicobacter pylori in gastric carcinogenesis", World J Gastrointest Oncol, 7, pp.455~465 (2015)
- Huang L, "Epithelial-mesenchymal transition in gastric cancer", Am J Transl Res, 7, pp.2141~2158 (2015)
- Dixon MF, "Classification and grading of gastritis : the updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994", Am J Surg Pathol, 20, pp.1161~1181 (1996)
- Yang HJ, "Helicobacter pylori-induced modulation of the promoter methylation of Wnt antagonist genes in gastric carcinogenesis", Gastric Cancer, 21, pp.237~248 (2018)
- 김나영, "The Effect of Helicobacter pylori on Epidermal Growth Factor Receptor- Induced Signal Transduction and the Preventive Effect of Celecoxib in Gastric Cancer Cells", Gut and Liver, 7(5), pp.552~559 (2013), 거트앤리버 소화기연관학회협의회
- Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))Method", Methods, 25, pp.402~408 (2001)
- Trinh BN, "DNA methylation analysis by MethyLight technology", Methods, 25, pp.456~462 (2001)
- Eads CA, "MethyLight : a high-throughput assay to measure DNA methylation", Nucleic Acids Res, 28, pp.E32~ (2000)
- Ushijima T, "Molecular pathways : involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers", Clin Cancer Res, 18, pp.923~929 (2012)
- Lamb A, "Role of the Helicobacter pylori-induced inflammatory response in the development of gastric cancer", J Cell Biochem, 114, pp.491~497 (2013)
- Wang F, "Helicobacter pylori-induced gastric inflammation and gastric cancer", Cancer Lett, 345, pp.196~202 (2014)
- Hwang YJ, "Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication : a prospective study for up to 10 years", Aliment Pharmacol Ther, 47, pp.380~390 (2018)
- Tahara T, "Examination of whole blood DNA methylation as a potential risk marker for gastric cancer", Cancer Prev Res(Phila), 6, pp.1093~1100 (2013)
- Rathinam R, "Role of Rho GTPases and their regulators in cancer progression", Front Biosci(Landmark Ed), 16, pp.2561~2571 (2011)
- Makino Y, "Elmo1 inhibits ubiquitylation of Dock180", J Cell Sci, 119(Pt 5), pp.923~932 (2006)
- Ramachandran K, "DNA methylation and field cancerization", Epigenomics, 4, pp.243~245 (2012)